167 related articles for article (PubMed ID: 27046219)
1. Delirium associated with concomitant use of duloxetine and bupropion in an elderly patient.
Ma SP; Tsai CJ; Chang CC; Hsu WY
Psychogeriatrics; 2017 Mar; 17(2):130-132. PubMed ID: 27046219
[TBL] [Abstract][Full Text] [Related]
2. Agitated delirium associated with therapeutic doses of sustained-release bupropion.
Mack DR; Barbarello-Andrews L; Liu MT
Int J Clin Pharm; 2012 Feb; 34(1):9-12. PubMed ID: 22108791
[TBL] [Abstract][Full Text] [Related]
3. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations.
Jefferson JW; Pradko JF; Muir KT
Clin Ther; 2005 Nov; 27(11):1685-95. PubMed ID: 16368442
[TBL] [Abstract][Full Text] [Related]
4. Bupropion-induced neck and shoulder pain.
Sansone RA; Sansone LA
Pharmacopsychiatry; 2009 Sep; 42(5):203-4. PubMed ID: 19724984
[No Abstract] [Full Text] [Related]
5. Delirium caused by a drug-drug interaction between bupropion and risperidone.
Lu YY; Hsueh JH; Wei IH; Huang CC
J Clin Psychopharmacol; 2014 Feb; 34(1):161-2. PubMed ID: 24346746
[No Abstract] [Full Text] [Related]
6. Augmentation of venlafaxine with bupropion: risks associated with a triple monoamine reuptake inhibition approach to partially responsive depression.
Andrade C
J Clin Psychiatry; 2013 Feb; 74(2):e119-21. PubMed ID: 23473356
[No Abstract] [Full Text] [Related]
7. The combination of duloxetine and bupropion for treatment-resistant major depressive disorder.
Papakostas GI; Worthington JJ; Iosifescu DV; Kinrys G; Burns AM; Fisher LB; Homberger CH; Mischoulon D; Fava M
Depress Anxiety; 2006; 23(3):178-81. PubMed ID: 16528701
[TBL] [Abstract][Full Text] [Related]
8. Delirium associated with concomitant use of low-dose bupropion sustained release and fluoxetine.
Chan CH; Liu HC; Huang MC
J Clin Psychopharmacol; 2006 Dec; 26(6):677-9. PubMed ID: 17110836
[No Abstract] [Full Text] [Related]
9. Bupropion plasma levels and CYP2D6 phenotype.
Pollock BG; Sweet RA; Kirshner M; Reynolds CF
Ther Drug Monit; 1996 Oct; 18(5):581-5. PubMed ID: 8885123
[TBL] [Abstract][Full Text] [Related]
10. Acute dystonia resulting from abrupt bupropion discontinuation.
Wang HY; Chou WJ; Huang TY; Hung CF
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):766-8. PubMed ID: 17218049
[TBL] [Abstract][Full Text] [Related]
11. Bupropion in the treatment of major depressive disorder in real-life practice.
Sennfelt DA; Marques da Silva MA; Tavares AP
Clin Drug Investig; 2011 Oct; 31 Suppl 1():19-24. PubMed ID: 22015859
[TBL] [Abstract][Full Text] [Related]
12. Bupropion: efficacy and safety in the treatment of depression.
Saiz Ruiz J; Gibert J; Gutiérrez Fraile M; Bobes J; Vallejo J; Iglesias C; Iriarte V
Actas Esp Psiquiatr; 2011; 39 Suppl 1():1-25. PubMed ID: 22983817
[No Abstract] [Full Text] [Related]
13. Two acute psychotic episodes after administration of bupropion: a case of involuntary rechallenge.
Javelot H; Baratta A; Weiner L; Javelot T; Nonnenmacher C; Westphal JF; Messaoudi M
Pharm World Sci; 2009 Apr; 31(2):238-40. PubMed ID: 19039677
[TBL] [Abstract][Full Text] [Related]
14. An open-label, rater-blinded, 8-week trial of bupropion hydrochloride extended-release in patients with major depressive disorder with atypical features.
Seo HJ; Lee BC; Seok JH; Jeon HJ; Paik JW; Kim W; Kwak KP; Han C; Lee KU; Pae CU
Pharmacopsychiatry; 2013 Sep; 46(6):221-6. PubMed ID: 23963965
[TBL] [Abstract][Full Text] [Related]
15. Bupropion sustained release: side effect profile.
Settle EC
J Clin Psychiatry; 1998; 59 Suppl 4():32-6. PubMed ID: 9554319
[TBL] [Abstract][Full Text] [Related]
16. Perceptual disturbances associated with low-dose bupropion sustained-release treatment.
Liu CY; Chien YS
J Clin Psychopharmacol; 2007 Oct; 27(5):543-4. PubMed ID: 17873707
[No Abstract] [Full Text] [Related]
17. Efficacy of bupropion XR in treatment-resistant elderly patients: a case series study.
Bergman J; Miodownik C; Palatnik A; Lerner V
Clin Neuropharmacol; 2011; 34(1):17-20. PubMed ID: 21206361
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder.
Hewett K; Chrzanowski W; Jokinen R; Felgentreff R; Shrivastava RK; Gee MD; Wightman DS; O'Leary MC; Millen LS; Leon MC; Briggs MA; Krishen A; Modell JG
J Psychopharmacol; 2010 Apr; 24(4):521-9. PubMed ID: 19164492
[TBL] [Abstract][Full Text] [Related]
19. Effect of treatment with bupropion on EEG sleep: relationship to antidepressant response.
Ott GE; Rao U; Lin KM; Gertsik L; Poland RE
Int J Neuropsychopharmacol; 2004 Sep; 7(3):275-81. PubMed ID: 15122973
[TBL] [Abstract][Full Text] [Related]
20. Bupropion: pharmacology and therapeutic applications.
Foley KF; DeSanty KP; Kast RE
Expert Rev Neurother; 2006 Sep; 6(9):1249-65. PubMed ID: 17009913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
